For the agar dilution method, the following antibiotics were tested: ampicillin, ciprofloxacin, erythromycin and tetracycline (Sigma Chemical Co., St Louis, MO, USA). For the disc diffusion testing, nalidixic acid (30 g) (Oxoid, Unipath Ltd, Basingstoke, UK), ampicillin (10 g), ciprofloxacin (5 g), erythromycin (15 g ) and tetracycline (30 g) (BBL, Becton Dickinson and Co., Cockeysville, MD, USA) discs were used.
Antibiotic susceptibility testing
The agar dilution method was performed as described previously, 6 the concentrations of the antibiotics tested were 0.06-256 mg/L and a control plate without antibiotic was inoculated at the end of the procedure. Inocula were prepared in Mueller-Hinton broth (BBL Microbiology Systems) at a density adjusted to a 0. 5 McFarland turbidity standard for the disc diffusion and diluted 1:10 for the agar dilution. With a Steers Cathra 3 mm, a final inoculum of about 10 4 cfu was placed on Mueller-Hinton agar plates (Difco Laboratories, Detroit, MI, USA). The same medium was used for the disc diffusion testing. The inoculated plates were incubated at 35°C under a microaerophilic atmosphere obtained with a gas generator envelope (Difco), for 48 h. For the agar dilution, the endpoint was taken as the complete inhibition of macroscopic growth; for the disc diffusion, the zone diameters were measured with slipping callipers. The following control strains were used: Staphylococcus aureus ATCC 25923, S. aureus ATCC 29213 and Escherichia coli ATCC 25922. Susceptibility criteria for the agar dilution method and the drug concentrations in the discs were those of the National Committee for Clinical Laboratory Standards. 7 The breakpoints used for the disc diffusion method are those mentioned in the Results section.
Results
The results of susceptibility testing using the disc diffusion and the agar dilution methods for each antibiotic are reported in the There was complete agreement between disc diffusion and the MICs of ciprofloxacin; this correlation is shown in Figure 1 . The 132 ciprofloxacin-susceptible strains (MIC 1 mg/L) had zone diameters of 28.2 mm, while the 13 resistant strains (MIC 4 mg/L) had zones of 15.2 mm. The correlation coefficient was 0.61.
The correlation of disc diffusion of nalidixic acid and the MICs of ciprofloxacin is shown in Figure 2 . Of the 132 ciprofloxacin-susceptible strains, 129 had zone diameters of 20.8 mm and one of 12 mm around the nalidixic acid disc. The 13 ciprofloxacin-resistant strains had no zone around this disc. Two susceptible strains had no zone for a major error of 1.4% to nalidixic acid disc. The correlation coefficient was 0.52.
The correlation of the two susceptibility methods for tetracycline is shown in Figure 3 . The 89 tetracycline-susceptible and 53 tetracycline-resistant Campylobacter spp. had zone diameters of 29 mm and 17 mm for complete agreement between both methods. The correlation coefficient was 0.78. The correlation of disc diffusion and agar dilution for erythromycin is shown in Figure 4 . The non-resistant strains (MIC 4 mg/L) had zone diameters of 20 mm. Four strains with high-level resistance (MIC 128 mg/L) had no zone around the erythromycin disc. Two strains with an MIC of 8 mg/L had zone diameters of 19.5 and 22.4 mm. There was a very major error of 0.7% if 20 mm was used as the criterion of non-resistance and the correlation coefficient was 0.66.
The correlation of the two susceptibility methods for ampicillin is shown in Figure 5 . Out of the 126 susceptible, 122 strains and three with an intermediate MIC had zone diameters of 14 mm around the ampicillin disc. Two intermediate and two susceptible Campylobacter spp. had zones of 6 but 14 mm. The 11 resistant, three intermediate and two susceptible strains had no zone around this disc. There were 5.5% minor and 1.4% major errors for disc diffusion for this antibiotic. The correlation coefficient was 0.57.
Discussion
In C. jejuni and C. coli, resistance to ciprofloxacin has increased from 0% to 2-50% in the last decade. 2, 4, 8 The MICs for susceptible C. jejuni and C. coli strains are 10-30 times higher than the MICs for susceptible Enterobacteriaceae and the DNA gyrase of these bacteria is intrinsically more resistant. 9 The MICs for resistant C. jejuni and C. coli strains are 8-256 times higher than those for susceptible strains. 8, 9 Resistance to the new quinolones is secondary to a single mutation causing a change in the A subunit of DNA gyrase. 9, 10 Microbiological failure with or without clinical failure as a consequence of the emergence of a resistant C. jejuni in patients treated with ciprofloxacin has been reported. 8 Nalidixic acid susceptibility is a marker for C. jejuni and C. coli ciprofloxacin susceptibility: the nalidixic acid-susceptible strains are susceptible to ciprofloxacin while most of the resistant ones are resistant to ciprofloxacin. 2, 3 The correlation between MICs and disc diffusion for ciprofloxacin was studied by Endtz et al.:
2 21 susceptible and 21 resistant C. jejuni or C. coli strains (MIC 1 mg/L and 4 mg/L respectively) had zone diameters of 26 and 17 mm respectively. If these strains were added to ours, the 95% CI for ciprofloxacin-resistant strains would be 89.8-100%.
Between 0 and 60% of C. jejuni and C. coli strains are reported to be resistant to tetracycline. 4, 11, 12 Resistance to this antibiotic in these bacteria is mainly plasmid-mediated, 4 a fact that might explain the complete agreement between disc diffusion and MICs for this antibiotic with 95% CI of 93% in our study. The plasmid-carrying strains are resistant to tetracycline and those without plasmids are susceptible. Tetracycline is considered an alternative treatment for diarrhoea caused by these Campylobacter spp.
Resistance to erythromycin has been reported in 0-12.6% of C. jejuni 3, 4, 11 and in 10-91% of C. coli. [3] [4] [5] As reported by others, 3, 5, 13 The breakpoint for resistance to erythromycin might have to be changed. 12 The strains with an MIC of 8 mg/L might not be truly resistant. 3 The efficacy of erythromycin in the treatment of C. jejuni enterocolitis has been demonstrated in clinical studies. 1, 14 -Lactamase is found in 83-92% of C. jejuni 6 and in 68-93.5% of C. coli. 5 The -lactamase-positive strains of Campylobacter spp. are significantly less susceptible to ampicillin, amoxycillin and ticarcillin even if the MICs produced are not high enough to be regarded as resistant. 5, 6 Ampicillin is not considered useful for the treatment of C. jejuni and C. coli infections. 1, 14 Vanhoof et al. 15 reported good correlation between disc diffusion and agar dilution for susceptibility testing of C. jejuni to many antibiotics. However, they used discs with drug concentrations not usually recommended by NCCLS. 12 In this study, we found the disc diffusion to be a reliable, easy and inexpensive method for testing the susceptibility of C. jejuni and C. coli to erythromycin, tetracycline and ciprofloxacin. The price for each disc is about US$0.03 compared with US$2.10 for one Etest antimicrobial strip. Until more erythromycin-and ciprofloxacinresistant strains are tested to confirm the reliability of this test, the resistance to these two drugs needs to be confirmed using the Etest 13 or the agar dilution method. 
